Improving adherence to and persistence with oral therapy of osteoporosis.

Improving adherence to and persistence with oral therapy of osteoporosis.

Item
http://www.wikidata.org/entity/Q41529661
T cells, osteoblasts, and osteocytes: interacting lineages key for the bone anabolic and catabolic activities of parathyroid hormone.Adherence to alendronic or risedronic acid treatment, combined or not to calcium and vitamin D, and related determinants in Italian patients with osteoporosis.Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation.Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study.Non-adherence with bisphosphonates among patients with osteoporosis: impact on fracture risk and healthcare cost‏.Bone-seeking agents for the treatment of bone disorders.A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates.How the knowledge of fracture risk might influence adherence to oral therapy of osteoporosis in Italy: the ADEOST study.
P2860

Improving adherence to and persistence with oral therapy of osteoporosis.

Item
http://www.wikidata.org/entity/Q41529661
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Improving adherence to and persistence with oral therapy of osteoporosis.
@en
type
label
Improving adherence to and persistence with oral therapy of osteoporosis.
@en
prefLabel
Improving adherence to and persistence with oral therapy of osteoporosis.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P6179
P698
P356
P1433
P1476
Improving adherence to and persistence with oral therapy of osteoporosis
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P6179
P698